The Vaccine Group makes significant progress with COVID-19 animal vaccines
Portfolio company The Vaccine Group has made significant progress in developing animal vaccines based on its novel technology to tackle COVID-19.
The Vaccine Group starts work on COVID-19 animal vaccine
Move follows significant progress across several projects
The Vaccine Group starts work on COVID-19 animal vaccine, makes strong progress with technology
The Vaccine Group is today announcing it has made significant progress towards developing its novel vaccine platform technology
The Vaccine Group raises £680,000 through initial equity fund raise
The Vaccine Group (TVG) has raised £680,000 through its first equity funding round.
The Vaccine Group wins grant from Department of Health and Social Care
The Vaccine Group has won a £403,000 grant as part of a £1.46 million Anglo-Chinese project to combat an emerging antibiotic-resistant disease able to jump from pigs to humans with potentially fatal effect